Phospho-NOS1 (S852) Antibody

What is the specificity profile of Phospho-NOS1 (S852) antibody?

Phospho-NOS1 (S852) antibody specifically detects endogenous levels of NOS1 protein only when phosphorylated at Serine 852 in human samples . The antibody also recognizes mouse and rat NOS1 protein when phosphorylated at the corresponding site (Serine 847) . This high specificity allows researchers to distinguish between phosphorylated and non-phosphorylated forms of NOS1, which is crucial for studying regulatory mechanisms of NOS1 activity in various physiological and pathological processes.

Most commercial antibodies are affinity-purified from rabbit antiserum using epitope-specific immunogen chromatography to ensure specificity, with purity levels typically exceeding 95% as confirmed by SDS-PAGE .

What are the recommended applications for Phospho-NOS1 (S852) antibody?

The antibody has been validated for multiple applications with specific recommended dilutions:

These applications have been tested with human, mouse, rat, and monkey samples, showing consistent and reproducible results across species .

What are the optimal storage conditions for maintaining antibody activity?

For long-term storage, Phospho-NOS1 (S852) antibody should be stored at -20°C or -80°C . The antibody is typically supplied in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide at approximately pH 7.2, which helps maintain stability .

How should I design validation experiments to confirm Phospho-NOS1 (S852) antibody specificity?

Validation experiments are crucial to confirm antibody specificity before proceeding with experimental studies. A comprehensive validation approach should include:

• Blocking peptide experiments: Compare staining patterns with and without pre-incubation of the antibody with the phospho-peptide used as the immunogen. Complete signal abolishment in the presence of phospho-peptide confirms specificity .

• Phosphatase treatment: Treat one set of samples with lambda phosphatase prior to antibody incubation. Loss of signal in phosphatase-treated samples confirms phospho-specificity .

• Multiple detection methods: Confirm results using at least two different techniques (e.g., WB and IHC or IF) .

• Knockout/knockdown controls: Use NOS1 knockout tissues or cells, or siRNA-mediated knockdown samples as negative controls .

• Cross-reactivity testing: Test the antibody against other phosphorylated proteins to ensure no cross-reactivity with similar phosphorylation motifs .

What are the critical considerations for sample preparation when detecting phosphorylated NOS1?

Effective sample preparation is vital for accurate detection of phosphorylated proteins:

• Rapid sample processing: Phosphorylation states can change rapidly; samples should be processed immediately after collection or flash-frozen in liquid nitrogen .

• Phosphatase inhibitors: Include multiple phosphatase inhibitors in lysis buffers (e.g., sodium fluoride, sodium orthovanadate, β-glycerophosphate, and phosphatase inhibitor cocktails) .

• Appropriate lysis buffer: Use RIPA buffer supplemented with protease inhibitors for most applications. For co-immunoprecipitation studies, consider milder non-ionic detergent buffers .

• Sample denaturation: For Western blotting, samples should be denatured at 95°C for 5 minutes in Laemmli buffer containing SDS and reducing agents .

• Tissue fixation for IHC/IF: Use 4% paraformaldehyde or 10% neutral buffered formalin with careful optimization of fixation time to preserve phospho-epitopes while maintaining tissue morphology .

How does phosphorylation at S852 affect NOS1 function and what methods can be used to study this relationship?

Phosphorylation at S852 in human NOS1 (S847 in rodents) is a key regulatory mechanism that modulates NOS1 enzymatic activity. Current research indicates this modification typically decreases NOS1 activity by reducing calmodulin binding .

Methods to study this relationship include:

• Activity assays: Compare nitric oxide production in systems with varying levels of S852 phosphorylation using colorimetric or fluorometric nitric oxide detection assays .

• Site-directed mutagenesis: Generate phospho-mimetic (S852D/E) or phospho-deficient (S852A) mutants to study the functional consequences of constitutive phosphorylation or dephosphorylation .

• Calcium imaging: Assess how S852 phosphorylation affects calcium-dependent activation of NOS1 using calcium-sensitive fluorescent dyes or protein-based calcium sensors .

• Protein-protein interaction studies: Employ co-immunoprecipitation or proximity ligation assays to examine how phosphorylation alters NOS1 interactions with calmodulin, PDZ domain proteins, or other binding partners .

• Single-cell analysis: Combine immunofluorescence for phospho-NOS1 with activity-dependent markers to correlate phosphorylation status with cellular activity in situ .

What are the best practices for quantitative analysis of Phospho-NOS1 (S852) levels?

Accurate quantification of phosphorylation levels requires careful methodological approaches:

• Normalization strategies: Always normalize phospho-NOS1 levels to total NOS1 protein rather than housekeeping proteins alone to account for variations in total protein expression .

• Standard curve generation: For ELISA applications, generate a standard curve using recombinant phosphorylated protein or phosphopeptide standards .

• Signal linearity assessment: Confirm signal linearity by loading different amounts of protein to ensure measurements fall within the dynamic range of detection .

• Multiple time points: When studying phosphorylation dynamics, collect samples at multiple time points to capture the complete kinetic profile .

• Statistical considerations: Use appropriate statistical tests for phosphoproteomics data, which often shows non-normal distributions. Consider specialized analysis packages designed for phosphoproteomic datasets .

What are the common causes of weak or inconsistent Phospho-NOS1 (S852) signals and their solutions?

How can I optimize immunoprecipitation protocols for Phospho-NOS1 (S852) antibody?

Successful immunoprecipitation of phosphorylated NOS1 requires specific optimizations:

• Buffer selection: Use mild lysis buffers (e.g., 1% NP-40 or 0.5% Triton X-100) with phosphatase inhibitors to preserve native protein structure and phosphorylation .

• Antibody-to-lysate ratio: Start with 2-5 μg antibody per 500 μg total protein and adjust based on results .

• Pre-clearing step: Pre-clear lysates with protein A/G beads to reduce non-specific binding .

• Antibody binding conditions: Incubate antibody with lysate overnight at 4°C with gentle rotation to maximize antigen-antibody interaction .

• Washing stringency: Balance between removing non-specific binding and preserving specific interactions. Start with 3-5 washes using lysis buffer, then optimize if needed .

• Elution methods: Compare mild elution (using excess phosphopeptide) versus denaturing elution (SDS buffer) depending on downstream applications .

• Verification: Always confirm successful IP by Western blot, probing for both phospho-NOS1 and total NOS1 .

How can Phospho-NOS1 (S852) antibody be applied in tissue-specific and subcellular localization studies?

Phospho-NOS1 (S852) shows distinctive localization patterns that can be studied using specialized techniques:

• Tissue-specific expression: Phospho-NOS1 is particularly abundant in neuronal tissues, skeletal muscle, and certain epithelial cells. Comparative immunohistochemistry studies across tissues can reveal tissue-specific phosphorylation patterns and regulation .

• Subcellular fractionation: Combine with subcellular fractionation techniques to determine whether phosphorylation affects NOS1 distribution between membrane, cytosolic, and nuclear compartments .

• Super-resolution microscopy: Employ techniques like STORM or PALM for nanoscale localization of phosphorylated NOS1 relative to specific subcellular structures .

• Multi-color immunofluorescence: Co-stain with markers of specific subcellular compartments (synapses, endoplasmic reticulum, mitochondria) to determine how phosphorylation affects NOS1 targeting .

• In vivo imaging: Develop phospho-specific biosensors based on this antibody epitope for real-time monitoring of NOS1 phosphorylation in living cells .

What are emerging research directions involving Phospho-NOS1 (S852) in pathological conditions?

Emerging research indicates that aberrant NOS1 phosphorylation at S852 may contribute to various pathological conditions:

• Neurodegenerative disorders: Altered phosphorylation patterns may contribute to excitotoxicity in conditions such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis .

• Cardiovascular diseases: Dysregulation of NOS1 phosphorylation may impact cardiac function and vascular tone in heart failure and hypertension .

• Cancer biology: NOS1 activity modulation through phosphorylation could influence tumor microenvironment and cancer progression in specific malignancies .

• Metabolic disorders: Recent evidence suggests links between NOS1 phosphorylation status and insulin resistance or metabolic syndrome .

• Inflammatory conditions: Phosphorylation-dependent regulation of nitric oxide production may alter inflammatory responses in chronic inflammatory diseases .

Future research directions should focus on developing therapeutic strategies targeting specific phosphorylation events to modulate NOS1 activity in these pathological contexts.